Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 67 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 6630572

    Thrombin derived polypeptides: compositions and methods for use

    The Board of Regents of the University of Texas System · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  2. US 6627731

    Thrombin derived polypeptides; compositions and methods for use

    The Board of Regents of the University of Texas System · Granted Sep 30, 2003 · Expires Sep 25, 2023

    expired

  3. US 6627189

    Inhibition of cellular proliferation using ras antisense molecules

    The Board of Regents of the University of Texas System · Granted Sep 30, 2003 · Expires Sep 25, 2023

    expired

  4. US 6623957

    Secretion of T cell receptor fragments from recombinant host cells

    The Board of Regents of the University of Texas System · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired

  5. US 6613757

    COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

    The Board of Regents of the University of Texas System · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  6. US 6608026

    Apoptotic compounds

    The Board of Regents of the University of Texas System · Granted Aug 19, 2003 · Expires Aug 14, 2023

    expired

  7. US 6602975

    Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers

    The Board of Regents of the University of Texas System · Granted Aug 5, 2003 · Expires Jul 31, 2023

    expired

  8. US 6596296

    Drug releasing biodegradable fiber implant

    The Board of Regents of the University of Texas System · Granted Jul 22, 2003 · Expires Jul 17, 2023

    expired

  9. US 6593306

    Methods for modulation and inhibition of telomerase

    The Board of Regents of the University of Texas System · Granted Jul 15, 2003 · Expires Jul 10, 2023

    expired

  10. US 6586242

    TAO protein kinases and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Jul 1, 2003 · Expires Jun 26, 2023

    expired

  11. US 6582725

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Jun 24, 2003 · Expires Jun 19, 2023

    expired

  12. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 17, 2003 · Expires Jun 12, 2023

    expired

  13. US 6576264

    Insoluble drug delivery

    The Board of Regents of the University of Texas System · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired

  14. US 6566500

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted May 20, 2003 · Expires May 15, 2023

    expired

  15. US 6562801

    PpGpp and pppGpp as immunomodulatory agents

    The Board of Regents of the University of Texas System · Granted May 13, 2003 · Expires May 8, 2023

    expired

  16. US 6551774

    Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity

    The Board of Regents of the University of Texas System · Granted Apr 22, 2003 · Expires Apr 17, 2023

    expired

  17. US 6551830

    Rh blood group antigen compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 22, 2003 · Expires Apr 17, 2023

    expired

  18. US 6537804

    BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth

    The Board of Regents of the University of Texas System · Granted Mar 25, 2003 · Expires Mar 20, 2023

    expired

  19. US 6524583

    Antibody methods for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Feb 25, 2003 · Expires Feb 20, 2023

    expired

  20. US 6517828

    C-CAM as an angiogenesis inhibitor

    The Board of Regents of the University of Texas System · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

  21. US 6518063

    Osf2/Cbfa1 nucleic acids and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

  22. US 6515118

    DNA fragmentation factor

    The Board of Regents of the University of Texas System · Granted Feb 4, 2003 · Expires Jan 30, 2023

    expired

  23. US 6514942

    Methods and compositions for stimulating T-lymphocytes

    The Board of Regents of the University of Texas System · Granted Feb 4, 2003 · Expires Jan 30, 2023

    expired

  24. US 6511847

    Recombinant p53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System · Granted Jan 28, 2003 · Expires Jan 23, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.